ArticleJournal of acquired immune deficiency syndromes (1999)2016

Brief Report: A Phase 1b/Pharmacokinetic Trial of PTC299, a Novel PostTranscriptional VEGF Inhibitor, for AIDS-Related Kaposi's Sarcoma: AIDS Malignancy Consortium Trial 059.

Rachel A Bender Ignacio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.